REGISTERED NUMBER: 06437975 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

INTERX CLINIC LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

Dr Z Valeyeva-Frost

SECRETARY:

J Korowajczyk

REGISTERED OFFICE:

Kingscott Dix

7 Rockfield Business Park

Old Station Drive

Cheltenham

Gloucestershire

GL53 0AN

REGISTERED NUMBER:

06437975 (England and Wales)

ACCOUNTANTS:

Kingscott Dix (Cheltenham) Limited

7 Rockfield Business Park

Old Station Drive

Leckhampton

Cheltenham

GL53 0AN

FIXED ASSETS

Tangible assets

4

4,392

5,060

CURRENT ASSETS

Debtors

5

16,481

3,005

Cash at bank

21,015

42,623

37,496

45,628

CREDITORS

Amounts falling due within one year

6

(12,069

)

(12,592

)

NET CURRENT ASSETS

25,427

33,036

TOTAL ASSETS LESS CURRENT LIABILITIES

29,819

38,096

CAPITAL AND RESERVES

Called up share capital

5

5

Retained earnings

29,814

38,091

SHAREHOLDERS' FUNDS

29,819

38,096

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss account has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 June 2026 and were signed by:

Dr Z Valeyeva-Frost - Director

1.	STATUTORY INFORMATION

Interx Clinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates

The following judgements and estimates have been used by the director in preparing the financial statements: estimated useful economic life of tangible fixed assets and recoverability of debtors.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

20% on reducing balance

Fixtures and fittings

-

20% on reducing balance

Computer equipment

-

25% on cost

Financial instruments

The company has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Plant and

and

Computer

machinery

fittings

equipment

Totals

£

£

£

£

COST

At 1 January 2025

8,088

1,848

15,545

25,481

Additions

-

-

999

999

At 31 December 2025

8,088

1,848

16,544

26,480

DEPRECIATION

At 1 January 2025

7,129

1,076

12,216

20,421

Charge for year

240

155

1,272

1,667

At 31 December 2025

7,369

1,231

13,488

22,088

NET BOOK VALUE

At 31 December 2025

719

617

3,056

4,392

At 31 December 2024

959

772

3,329

5,060

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

6,731

3,005

Other debtors

9,750

-

16,481

3,005

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

1,958

-

Tax

7,095

8,200

Social security and other taxes

(1

)

-

VAT

804

1,807

Directors' current accounts

-

415

Accrued expenses

2,213

2,170

12,069

12,592